Bayersp. z o.o.

Wholesale of chemical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-14
Share capital
151 340 000,00 PLN
Activity description

Bayer supplies prescription and OTC medicines, crop protection and consumer-health products in Poland under Bayer and Berocca. It serves pharmacies, agriculture and medical distributors.

Registered address
al. Jerozolimskie 158, 02-326 Warszawa, Poland
Website
talent.bayer.comWebsite active
Electronic delivery address
AE:PL-60850-71481-WBAHC-25

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 624.31mMedianUSD 684.56kAverageUSD 9.03m
Net profit
This companyUSD 20.03mMedianUSD 12.12kAverageUSD 315.36k
Operating costs
This companyUSD 597.22mMedianUSD 639.62kAverageUSD 8.25m
Assets
This companyUSD 244.73mMedianUSD 386.69kAverageUSD 4.75m

Bank accounts

Registered as a VAT taxpayer on 2003-10-31. Active

  • mBank
    26 1140 0039 0000 2479 1300 1003
  • mBank
    74 1140 1010 0000 3071 3500 1001
  • mBank
    80 1140 0039 0000 2479 1300 1001

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$1.6M
Buildings and premises
$8.4M

MSiG notices

Publication dateEvent
Jan 23, 2025Commercial Companies Code notice
Oct 31, 2024Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Tenders

364 tenders recorded as contractor: 74 national ($5,090,417) and 290 EU ($913,829,395).

SubjectAmount
31/26 – Dostawa produktów leczniczych
–
Dostawa produktów radiofarmaceutycznych dla Zakładu Medycyny Nuklearnej
–
Sukcesywna dostawa produktów leczniczych stosowanych w programach lekowych
–

Public sector contracts

Bayer is the contractor in 103 public sector contracts, worth PLN 13.50m in total. They were signed with 63 public buyers.

Public buyerValue
Krakowski Szpital Specjalistyczny Im. Św. Jana Pawła IIPLN 3,750
Zespół Opieki Zdrowotnej w DębicyPLN 5,370
Wojewódzki Szpital Specjalistyczny w OlsztyniePLN 246,240
Krakowski Szpital Specjalistyczny Im. Św. Jana Pawła IIPLN 10,500
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu MedycznegoPLN 1,534,723

Public procurement disputes (KIO)

Bayer has been a party to 2 cases before the National Appeal Chamber (since 2008). It filed 1 appeal (1 dismissed). In 1 case it joined the proceedings as a participant.

DateCase no.RoleOther partyOutcome
Jul 29, 2026KIO 3073/26Participant (on authority's side)Samodzielny Publiczny Wielospecjalistyczny Zakład Opieki Zdrowotnej w StargardzieUpheld
Jun 6, 2008KIO 510/08AppellantRadomski Szpital Specjalistyczny im. dr Tytusa ChałubińskiegoDismissed

Trademarks

Bayer holds 3 active trademarks registered with the Polish Patent Office. 51 marks have expired or were not registered. The first mark was filed in 1995.

MarkProtected until
APTECZKA FUTRZAKASep 18, 2027
traper(word)Apr 12, 2030
fantom(word)Mar 26, 2028
glonojad(word)–
glonojad(word)–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Bogusław Tobiasz – Attorney-in-fact (joint)
Simon Johannes Britsch – President of the Management Board
Lyndsay Sullivan – Management Board Member
Remigiusz Stanisław Wojciechowski – Attorney-in-fact (joint)
Tobias Smuda – Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently

Ownership

OwnerSharesShare valueStake
Bayer Global Investments B.v.
151,339$40,880,334.9599.9993%
Others
1$270.120.0007%

Beneficial owners

Person

Competitors

Name
Polska Grupa FarmaceutycznaS.A.
Basf Polskasp. z o.o.
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.
Brenntag Polskasp. z o.o.
HurtapS.A.
Centrala Farmaceutyczna CefarmS.A.
Sanofisp. z o.o.
USP Zdrowiesp. z o.o.
MSD Polska Dystrybucjasp. z o.o.
Medi&Moresp. z o.o.

Change history

DateEvent
2018-11-29Share capital change
2009-09-11Share capital change
2001-08-14Entered in the register

FAQ

Last updated: 2026-10-04